(Q42483926)

1 November 2017

title

Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. (English)

1 reference

1 November 2017

1 reference

1 reference

Mohammed Filali

1

1 reference

1 November 2017

Robert Lalonde

series ordinal

2

1 reference

1 November 2017

language of work or name

English

0 references

publication date

19 October 2015

1 reference

1 November 2017

1 reference

1 November 2017

volume

46

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

228-241

1 reference

https://scigraph.springernature.com/pub.10.1007/s10519-015-9753-3

1 November 2017

exact match

0 references

cites work

Range of neuropsychiatric disturbances in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Behavioural characterization of vitamin D receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Clinical progression in Parkinson disease and the neurobiology of axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

The Vps33a gene regulates behavior and cerebellar Purkinje cell number

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Age-dependent and -independent behavioral deficits in Tg2576 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Ataxia with loss of Purkinje cells in a mouse model for Refsum disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Motor activity in young APPswe + PS1/A246E bigenic mice as a predicting variable for memory decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Genetic mouse models of parkinsonism: strengths and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Normal and pathological gait: what we learn from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Development of SHIRPA to characterise the phenotype of gene-targeted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Behavioural recovery on simple and complex tasks by means of cell replacement therapy in unilateral 6-hydroxydopamine-lesioned mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Protocol for the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

PITX3 and risk for Parkinson's disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

alpha-Synucleinopathy models and human neuropathology: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Motor abnormalities in weaver mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Brain regions and genes affecting postural control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Characterization of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor coordination, exploratory activity, and spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Primary neurologic screening and motor coordination of Dstdt-J mutant mice (dystonia musculorum) with spinocerebellar atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Genetic factors involved in the pathogenesis of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

21 January 2018

Basal ganglia disease

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Animal models of the non-motor features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Pitx3 is required for development of substantia nigra dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ( 416insG ) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Nest building performance following MPTP toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

Expression of truncated PITX3 in the developing lens leads to microphthalmia and aphakia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10519-015-9753-3

10.1007/S10519-015-9753-3

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference